A Novel Multiplex ELISA Assay for Surveilling Patients with History of Bladder Cancer

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Bladder Cancer
Trial Locations (4)

75390

ACTIVE_NOT_RECRUITING

UT Southwestern Medical Center at Dallas, Dallas

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

94158

ACTIVE_NOT_RECRUITING

University of California San Francisco, San Francisco

Unknown

RECRUITING

Kyoto University Graduate School of Medicine, Kyoto

Sponsors
All Listed Sponsors
collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

University of Texas

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Nonagen Bioscience Corporation

INDUSTRY

collaborator

Kyoto University

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Cedars-Sinai Medical Center

OTHER